Multiple Sclerosis Market Research Report by Treatment Modality (Injectable Agents and Oral Agents), by Application (Hospital and Research) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Multiple Sclerosis Market is expected to grow from USD 13,277.24 Million in 2020 to USD 18,820.19 Million by the end of 2025.
2. The Global Multiple Sclerosis Market is expected to grow from EUR 11,641.73 Million in 2020 to EUR 16,501.90 Million by the end of 2025.
3. The Global Multiple Sclerosis Market is expected to grow from GBP 10,349.53 Million in 2020 to GBP 14,670.22 Million by the end of 2025.
4. The Global Multiple Sclerosis Market is expected to grow from JPY 1,417,018.14 Million in 2020 to JPY 2,008,591.73 Million by the end of 2025.
5. The Global Multiple Sclerosis Market is expected to grow from AUD 19,280.32 Million in 2020 to AUD 27,329.42 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Multiple Sclerosis to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Treatment Modality, the Multiple Sclerosis Market studied across Injectable Agents and Oral Agents.
Based on Application, the Multiple Sclerosis Market studied across Hospital and Research.
Based on Geography, the Multiple Sclerosis Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Multiple Sclerosis Market including AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Biogen Idec, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis International AG, Pfizer Inc., Sanofi Aventis, Synthetic Biologics, Inc., and Teva Pharmaceuticals Industries Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Multiple Sclerosis Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Multiple Sclerosis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Multiple Sclerosis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Multiple Sclerosis Market?
4. What is the competitive strategic window for opportunities in the Global Multiple Sclerosis Market?
5. What are the technology trends and regulatory frameworks in the Global Multiple Sclerosis Market?
6. What are the modes and strategic moves considered suitable for entering the Global Multiple Sclerosis Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Multiple Sclerosis Market is expected to grow from USD 13,277.24 Million in 2020 to USD 18,820.19 Million by the end of 2025.
2. The Global Multiple Sclerosis Market is expected to grow from EUR 11,641.73 Million in 2020 to EUR 16,501.90 Million by the end of 2025.
3. The Global Multiple Sclerosis Market is expected to grow from GBP 10,349.53 Million in 2020 to GBP 14,670.22 Million by the end of 2025.
4. The Global Multiple Sclerosis Market is expected to grow from JPY 1,417,018.14 Million in 2020 to JPY 2,008,591.73 Million by the end of 2025.
5. The Global Multiple Sclerosis Market is expected to grow from AUD 19,280.32 Million in 2020 to AUD 27,329.42 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Multiple Sclerosis to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Treatment Modality, the Multiple Sclerosis Market studied across Injectable Agents and Oral Agents.
Based on Application, the Multiple Sclerosis Market studied across Hospital and Research.
Based on Geography, the Multiple Sclerosis Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Multiple Sclerosis Market including AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Biogen Idec, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis International AG, Pfizer Inc., Sanofi Aventis, Synthetic Biologics, Inc., and Teva Pharmaceuticals Industries Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Multiple Sclerosis Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Multiple Sclerosis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Multiple Sclerosis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Multiple Sclerosis Market?
4. What is the competitive strategic window for opportunities in the Global Multiple Sclerosis Market?
5. What are the technology trends and regulatory frameworks in the Global Multiple Sclerosis Market?
6. What are the modes and strategic moves considered suitable for entering the Global Multiple Sclerosis Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Treatment Modality Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL MULTIPLE SCLEROSIS MARKET, BY TREATMENT MODALITY
6.1. Introduction
6.2. Injectable Agents
6.3. Oral Agents
7. GLOBAL MULTIPLE SCLEROSIS MARKET, BY APPLICATION
7.1. Introduction
7.2. Hospital
7.3. Research
8. AMERICAS MULTIPLE SCLEROSIS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. AbbVie Inc.
12.2. Bayer HealthCare Pharmaceuticals LLC
12.3. Biogen Idec
12.4. F. Hoffmann-La Roche AG
12.5. Merck & Co. Inc.
12.6. Novartis International AG
12.7. Pfizer Inc.
12.8. Sanofi Aventis
12.9. Synthetic Biologics, Inc.
12.10. Teva Pharmaceuticals Industries Ltd.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Treatment Modality Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL MULTIPLE SCLEROSIS MARKET, BY TREATMENT MODALITY
6.1. Introduction
6.2. Injectable Agents
6.3. Oral Agents
7. GLOBAL MULTIPLE SCLEROSIS MARKET, BY APPLICATION
7.1. Introduction
7.2. Hospital
7.3. Research
8. AMERICAS MULTIPLE SCLEROSIS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. AbbVie Inc.
12.2. Bayer HealthCare Pharmaceuticals LLC
12.3. Biogen Idec
12.4. F. Hoffmann-La Roche AG
12.5. Merck & Co. Inc.
12.6. Novartis International AG
12.7. Pfizer Inc.
12.8. Sanofi Aventis
12.9. Synthetic Biologics, Inc.
12.10. Teva Pharmaceuticals Industries Ltd.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY INJECTABLE AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY ORAL AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY RESEARCH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. ARGENTINA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. ARGENTINA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. BRAZIL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. BRAZIL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. CANADA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CANADA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. MEXICO MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. MEXICO MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AUSTRALIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AUSTRALIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CHINA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CHINA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. INDIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. INDIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDONESIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDONESIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. JAPAN MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. JAPAN MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MALAYSIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MALAYSIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. PHILIPPINES MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. PHILIPPINES MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. SOUTH KOREA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. SOUTH KOREA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. THAILAND MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. THAILAND MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. FRANCE MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. FRANCE MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. GERMANY MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. GERMANY MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ITALY MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ITALY MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. NETHERLANDS MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. NETHERLANDS MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. QATAR MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. QATAR MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. RUSSIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. RUSSIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. SAUDI ARABIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SAUDI ARABIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SPAIN MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SPAIN MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. UNITED ARAB EMIRATES MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED ARAB EMIRATES MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED KINGDOM MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED KINGDOM MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. GLOBAL MULTIPLE SCLEROSIS MARKET: SCORES
TABLE 70. GLOBAL MULTIPLE SCLEROSIS MARKET: BUSINESS STRATEGY
TABLE 71. GLOBAL MULTIPLE SCLEROSIS MARKET: PRODUCT SATISFACTION
TABLE 72. GLOBAL MULTIPLE SCLEROSIS MARKET: RANKING
TABLE 73. GLOBAL MULTIPLE SCLEROSIS MARKET: MERGER & ACQUISITION
TABLE 74. GLOBAL MULTIPLE SCLEROSIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 75. GLOBAL MULTIPLE SCLEROSIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 76. GLOBAL MULTIPLE SCLEROSIS MARKET: INVESTMENT & FUNDING
TABLE 77. GLOBAL MULTIPLE SCLEROSIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 78. GLOBAL MULTIPLE SCLEROSIS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY INJECTABLE AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY ORAL AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY RESEARCH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. ARGENTINA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. ARGENTINA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. BRAZIL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. BRAZIL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. CANADA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CANADA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. MEXICO MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. MEXICO MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AUSTRALIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AUSTRALIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CHINA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CHINA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. INDIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. INDIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDONESIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDONESIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. JAPAN MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. JAPAN MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MALAYSIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MALAYSIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. PHILIPPINES MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. PHILIPPINES MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. SOUTH KOREA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. SOUTH KOREA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. THAILAND MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. THAILAND MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. FRANCE MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. FRANCE MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. GERMANY MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. GERMANY MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ITALY MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ITALY MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. NETHERLANDS MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. NETHERLANDS MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. QATAR MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. QATAR MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. RUSSIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. RUSSIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. SAUDI ARABIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SAUDI ARABIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SPAIN MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SPAIN MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. UNITED ARAB EMIRATES MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED ARAB EMIRATES MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED KINGDOM MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED KINGDOM MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. GLOBAL MULTIPLE SCLEROSIS MARKET: SCORES
TABLE 70. GLOBAL MULTIPLE SCLEROSIS MARKET: BUSINESS STRATEGY
TABLE 71. GLOBAL MULTIPLE SCLEROSIS MARKET: PRODUCT SATISFACTION
TABLE 72. GLOBAL MULTIPLE SCLEROSIS MARKET: RANKING
TABLE 73. GLOBAL MULTIPLE SCLEROSIS MARKET: MERGER & ACQUISITION
TABLE 74. GLOBAL MULTIPLE SCLEROSIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 75. GLOBAL MULTIPLE SCLEROSIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 76. GLOBAL MULTIPLE SCLEROSIS MARKET: INVESTMENT & FUNDING
TABLE 77. GLOBAL MULTIPLE SCLEROSIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 78. GLOBAL MULTIPLE SCLEROSIS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL MULTIPLE SCLEROSIS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MULTIPLE SCLEROSIS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2020 (USD MILLION)
FIGURE 5. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL MULTIPLE SCLEROSIS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL MULTIPLE SCLEROSIS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2020 VS 2025 (%)
FIGURE 14. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2025
FIGURE 16. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY INJECTABLE AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY ORAL AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 19. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2025
FIGURE 21. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY HOSPITAL, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY RESEARCH, 2020 VS 2025 (USD MILLION)
FIGURE 23. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 24. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 26. ARGENTINA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. BRAZIL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. CANADA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. MEXICO MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 32. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 34. AUSTRALIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. CHINA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. INDIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. INDONESIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. JAPAN MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. MALAYSIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. PHILIPPINES MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. SOUTH KOREA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. THAILAND MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 44. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 46. FRANCE MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. GERMANY MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ITALY MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. NETHERLANDS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. QATAR MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. RUSSIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. SAUDI ARABIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SOUTH AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SPAIN MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. UNITED ARAB EMIRATES MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. UNITED KINGDOM MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. GLOBAL MULTIPLE SCLEROSIS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 58. GLOBAL MULTIPLE SCLEROSIS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 59. GLOBAL MULTIPLE SCLEROSIS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 60. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MULTIPLE SCLEROSIS MARKET, BY TYPE
FIGURE 1. GLOBAL MULTIPLE SCLEROSIS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MULTIPLE SCLEROSIS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2020 (USD MILLION)
FIGURE 5. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL MULTIPLE SCLEROSIS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL MULTIPLE SCLEROSIS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2020 VS 2025 (%)
FIGURE 14. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2025
FIGURE 16. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY INJECTABLE AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY ORAL AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 19. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2025
FIGURE 21. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY HOSPITAL, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY RESEARCH, 2020 VS 2025 (USD MILLION)
FIGURE 23. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 24. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 26. ARGENTINA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. BRAZIL MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. CANADA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. MEXICO MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 32. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 34. AUSTRALIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. CHINA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. INDIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. INDONESIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. JAPAN MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. MALAYSIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. PHILIPPINES MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. SOUTH KOREA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. THAILAND MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 44. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 46. FRANCE MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. GERMANY MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ITALY MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. NETHERLANDS MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. QATAR MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. RUSSIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. SAUDI ARABIA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SOUTH AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SPAIN MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. UNITED ARAB EMIRATES MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. UNITED KINGDOM MULTIPLE SCLEROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. GLOBAL MULTIPLE SCLEROSIS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 58. GLOBAL MULTIPLE SCLEROSIS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 59. GLOBAL MULTIPLE SCLEROSIS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 60. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MULTIPLE SCLEROSIS MARKET, BY TYPE
